| ADA | American Diabetes Association |
| ADP | Adenosine diphosphate |
| AGE | Advanced glycation end products |
| ALR2 | Aldose reductase |
| AMPK | AMP-activated protein kinase |
| AP-1 | Protein-1 activator |
| ATP | Adenosine triphosphate |
| Br | Bromine |
| 11β-HSD | 11β-Hydroxysteroid dehydrogenase |
| CAT | Catalase |
| Cl | Chlorine |
| CLX | Clobenzorex |
| CRP | C-reactive protein |
| DM | Diabetes Mellitus |
| DNA | Oxidative alterations in deoxyribonucleic acid |
| EGR-1 | Early-response growth factor |
| ER | Endoplasmic reticulum |
| F | Fluorine |
| GA | Golgi apparatus |
| GCK | glucokinase |
| GLUT | Glucose transporter |
| GPx | Glutathione peroxidase |
| GRed | Glutathione reductase |
| ∆G | Binding energy |
| HO | Hydroxyl radical |
| h | Hour(s) |
| IDF | International Diabetes Federation |
| IL-6 | Interleukin 6 |
| IR | Insulin receptor |
| Ki | Inhibition constant |
| LD50 | Median lethal dose |
| MAPK/Akt | Mitogen-activated protein kinase |
| mRNA | Gene expression, messenger ribonucleic acid |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NADPH | Reduced nicotinamide adenine dinucleotide phosphate |
| NF-κB | Nuclear factor kappa B |
| PI3K | Phosphatidylinositol-3-kinase |
| O2 | Superoxide anion radical |
| PGZ | Pioglitazone |
| PKC | Protein kinase C |
| PPAR | Peroxisome proliferator-activated receptor |
| PTP-1B | Protein tyrosine phosphatase 1B |
| ROS | Reactive oxygen species |
| Ser/Thr | Phosphorylation state in serine/threonine |
| RSG | Rosiglitazone |
| SOD | Superoxide dismutase |
| STZ | Streptozotocin |
| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| TNF-alpha | Tumor necrosis factor-alpha |
| VEGF | Vascular endothelial growth factor |
| WHO | World Health Organization |
| IC50 | Half maximal inhibitory concentration |